Pacific Biosciences of California, Inc. (NASDAQ:PACB) Q4 2024 Earnings Call Transcript February 13, 2025
Pacific Biosciences of California, Inc. beats earnings expectations. Reported EPS is $0.51, expectations were $-0.2.
Operator: Good day. And welcome to the PacBio Fourth Quarter 2024 Earnings Conference Call. All participants will be in listen-only mode. Please note today’s event is being recorded. I would now like to turn the conference over to Todd Friedman, Senior Director of Finance...
